Baker McKenzie advised Olink Holding AB (publ), a leader in next generation proteomics in its sale to Thermo Fisher Scientific (NYSE: TMO) in an all-cash transaction valued at approximately $3.1 billion (including net cash).
Co-led by partners Mark Mandel and Henric Roth together with Piotr Korzynski and Carl Svernlöv, the Baker McKenzie team includes:
• M&A/Capital Markets: Mark Mandel, Piotr Korzynski, Justin Bryant, Roger Bivans, Gwen Karanadze, Adam Buehler, Sarah Rodrigue, Lewis Assness, Shelly Kuo, Adeola Alade, Zach Bassen, Rachel Gray, Franchesca Alamo
• Stockholm M&A/Capital Markets: Henric Roth, Carl Svernlöv, Per Blom, Monica Ericson
• Antitrust: John Fedele, Heidi Smucker
• Benefits: Thomas Asmar, Sesen Hailemichael
• Foreign Investment: Rod Hunter, Alexandra Kumar
• Employment: Elizabeth Ebersole, Adeola Olowude, Amanda Cohen
• Stockholm Employment: Ida Cederborg and Amanda Thieme
• Environment: Jessica Wicha
• Intellectual Property: Adam Aft, Robby Turner
• International Commercial: Sylwia Lis, Lise Test,
• Real Estate: Sarah Winston, Sarah Swain, Amanda Jaramillo
• Tax: Kai Kramer, Ross Staine, Joseph Chung
• Stockholm Tax: Linnea Back, Ulrika Udén, Oskar Salenstedt
• Litigation: Peter Tomczak, Matthew Allison, Geoff Martin, Xin Tao
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.